If CYDY hires a competent CEO, with good credibility, I think the FDA will bend over backwards to give Leronlimab fair consideration knowing that its issues with the company were likely due to the incompetence of the previous CEO.
My opinion, for what it's worth.
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
The Lawmanstyle="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]